Skip to main content

Table 3 Clinical 30-day outcome

From: Does the “obesity paradox” exist after transcatheter aortic valve implantation?

Variable Overall (n = 109) BMI (kg/m2)
 < 21.9 (n = 27) 21.9–27.0 (n = 55)  > 27.0 (n = 27)
30-day Mortality 5 (4.6%) 1 (3.7%) 3 (5.5%) 1 (3.7%)
Cerebrovascular accident/transient ischemic attack 3 (2.8%) 1 (3.7%) 1 (1.8%) 1 (3.7%)
Myocardial infarction 2 (1.8%) 0 (0.0%) 1 (1.8%) 1 (3.7%)
Respiratory failure 7 (6.4%) 2 (7.4%) 3 (5.5%) 2 (7.4%)
Cardiogenic shock 3 (2.8%) 1 (3.7%) 2 (3.6%) 0 (0.0%)
Cardiac tamponade 1 (0.9%) 1 (3.7%) 0 (0.0%) 0 (0.0%)
Major bleeding 2 (1.8%) 1 (3.7%) 1 (1.8%) 0 (0.0%)
Major vascular complications 4 (3.7%) 1 (3.7%) 2 (3.6%) 1 (3.7%)
Minor vascular complications 8 (7.3%) 4 (14.8%) 3 (5.5%) 1 (3.7%)
New permanent pacemaker implantation 7 (6.4%) 2 (7.4%) 3 (5.5%) 2 (7.4%)
Acute kidney injury stage 3 13 (11.9%) 4 (14.8%) 7 (12.7%) 2 (7.4%)
New York Heart Association functional class 1.83 ± 0.7 1.81 ± 0.9 1.83 ± 0.9 1.80 ± 0.7
  1. Data are expressed as mean ± standard deviations (SD) or number (%)
  2. Chi-square or Fisher test for categorical variables and t text for continuous variables